Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA
Clinical trial NCT04636827 · UNKNOWN
Trial details
- NCT number
- NCT04636827
- Sponsor
- China National Biotec Group Company Limited
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-11
- Primary completion
- 2021-08-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.